beta-lactams has been researched along with indoline in 2 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (indoline) | Trials (indoline) | Recent Studies (post-2010) (indoline) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 427 | 0 | 286 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Liu, Y; Podoll, JD; Walls, S; Wang, W; Wang, X | 1 |
| Cleaver, L; Jolly, A; Podoll, JD; Walls, S; Wang, W; Wang, X; Zhu, Y | 1 |
2 other study(ies) available for beta-lactams and indoline
| Article | Year |
|---|---|
Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Biocompatible Materials; Catalysis; Cell Death; Cell Proliferation; Drug Evaluation, Preclinical; Drug Synergism; Gold; Hep G2 Cells; Humans; Indoles; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polycyclic Compounds | 2013 |
Tetracyclic indolines as a novel class of β-lactam-selective resistance-modifying agent for MRSA.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Synergism; Humans; Indoles; Methicillin-Resistant Staphylococcus aureus; Structure-Activity Relationship; Tetracyclines | 2017 |